Literature DB >> 15920129

Management of pregnancies with RhD alloimmunisation.

Sailesh Kumar1, Fiona Regan.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15920129      PMCID： PMC558098          DOI： 10.1136/bmj.330.7502.1255

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

Review 1.  Fetal transfusion for red blood cell alloimmunization in pregnancy.

Authors:  B Schumacher; K J Moise
Journal:  Obstet Gynecol       Date:  1996-07       Impact factor: 7.661

2.  Treatment of fetal erythroblastosis by intravascular transfusions: outcome at 6 years.

Authors:  D Grab; W E Paulus; A Bommer; G Buck; R Terinde
Journal:  Obstet Gynecol       Date:  1999-02       Impact factor: 7.661

3.  Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses.

Authors:  G Mari; R L Deter; R L Carpenter; F Rahman; R Zimmerman; K J Moise; K F Dorman; A Ludomirsky; R Gonzalez; R Gomez; U Oz; L Detti; J A Copel; R Bahado-Singh; S Berry; J Martinez-Poyer; S C Blackwell
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

4.  Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions.

Authors:  G R Saade; K J Moise; M A Belfort; D E Hesketh; R J Carpenter
Journal:  Fetal Diagn Ther       Date:  1993 May-Jun       Impact factor: 2.587

5.  Prenatal determination of fetal rhesus D status by DNA amplification of peripheral blood of rhesus-negative mothers.

Authors:  Y M Lo; P J Bowell; M Selinger; I Z Mackenzie; P Chamberlain; M D Gillmer; P Elliott; G Pratt; T J Littlewood; K A Fleming
Journal:  Ann N Y Acad Sci       Date:  1994-09-07       Impact factor: 5.691

6.  Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service.

Authors:  K M Finning; P G Martin; P W Soothill; N D Avent
Journal:  Transfusion       Date:  2002-08       Impact factor: 3.157

7.  Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease.

Authors:  L Hudon; K J Moise; S E Hegemier; R M Hill; A A Moise; E O Smith; R J Carpenter
Journal:  Am J Obstet Gynecol       Date:  1998-10       Impact factor: 8.661

8.  Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia.

Authors:  A Scaradavou; S Inglis; P Peterson; J Dunne; F Chervenak; J Bussel
Journal:  J Pediatr       Date:  1993-08       Impact factor: 4.406

9.  Intravenous Rh immune globulin prevents alloimmunization in D- granulocyte recipients but obscures the detection of an allo-anti-K.

Authors:  D F Stroncek; J L Procter; L Moses; C Bolan; G J Pomper; C Conroy-Cantilena; H L Malech; H G Klein; S F Leitman
Journal:  Immunohematology       Date:  2001

10.  Intrauterine fetal transfusion, 1963-90.

Authors:  N S Pattison; A B Roberts; N Mantell
Journal:  Ultrasound Obstet Gynecol       Date:  1992-09-01       Impact factor: 7.299
View more
  13 in total

1.  CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility.

Authors:  Hisham A E Awad; Azza A G Tantawy; Rania A El-Farrash; Eman A Ismail; Noha M Youssif
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

2.  Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008.

Authors:  Tobias Jörg Legler; Sina Patricia Müller; Alexander Haverkamp; Simon Grill; Sinuhe Hahn
Journal:  Transfus Med Hemother       Date:  2009-05-14       Impact factor: 3.747

3.  Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study.

Authors:  Kirstin Finning; Pete Martin; Joanna Summers; Edwin Massey; Geoff Poole; Geoff Daniels
Journal:  BMJ       Date:  2008-04-03

Review 4.  Disorders of the fetomaternal unit: hematologic manifestations in the fetus and neonate.

Authors:  L Vandy Black; Akhil Maheshwari
Journal:  Semin Perinatol       Date:  2009-02       Impact factor: 3.300

5.  Occurrence of anti-D alloantibodies among pregnant women in Kasese District, Western Uganda.

Authors:  Yona Mbalibulha; Enoch Muwanguzi; Godfrey R Mugyenyi; Bernard Natukunda
Journal:  J Blood Med       Date:  2015-04-17

6.  A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women.

Authors:  Ebru Dündar Yenilmez; Umut Kökbaş; Kezban Kartlaşmış; Levent Kayrın; Abdullah Tuli
Journal:  PLoS One       Date:  2018-06-06       Impact factor: 3.240

7.  High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysis.

Authors:  Huiqin Yang; Alexis Llewellyn; Ruth Walker; Melissa Harden; Pedro Saramago; Susan Griffin; Mark Simmonds
Journal:  BMC Med       Date:  2019-02-14       Impact factor: 8.775

8.  Mice expressing RHAG and RHD human blood group genes.

Authors:  Dominique Goossens; Nelly da Silva; Sylvain Metral; Ulrich Cortes; Isabelle Callebaut; Julien Picot; Isabelle Mouro-Chanteloup; Jean-Pierre Cartron
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

9.  Diagnosis of severe fetal anemia based on perinatal outcomes: a comparative analysis of the current reference values.

Authors:  Zilma Silveira Nogueira Reis; Gabriel Costa Osanan; Tiago Lanfernini Ricardo Coelho; Cezar Alencar De Lima Rezende; Henrique Vitor Leite; Antônio Carlos Vieira Cabral
Journal:  Anemia       Date:  2013-11-20

10.  Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study.

Authors:  Lyn S Chitty; Kirstin Finning; Angela Wade; Peter Soothill; Bill Martin; Kerry Oxenford; Geoff Daniels; Edwin Massey
Journal:  BMJ       Date:  2014-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.